Global Meningococcal Vaccines Market Size, Trends & Growth Opportunity By Vaccine Serotype (MenAC, MenA, MenC, MenB & Manic, and MenACWY), By Vaccine Type (Subcapsular, Polysaccharide, and Conjugate), By End User Channel (Adult, Pediatric, and Travelers), By Region and Forecast till 2027.
Market Overview
Global Meningococcal Vaccines Market was valued at 3.0 billion in 2021 which is expected to reach USD 4.95 billion by 2027 at CAGR 8.41 %from 2022-2027.
Fungi, bacteria, and viruses can all cause meningitis. Meningococcal meningitis is a bacterial form of meningitis caused by the bacterium Neisseria meningitides (meningococcus). Meningococcal meningitis is prevented with the use of meningococcal vaccinations.
Market Drivers
The increase in the number of reportable cases of meningococcal meningitis in the Sub-Saharan African region is the primary driving factor projected to promote the worldwide meningococcal vaccines market growth. For example, according to a World Economic Forum report, 37.4 million tourists visited Sub-Saharan Africa in 2018. Furthermore, an increase in government awareness initiatives, as well as an increase in government interventions in refining healthcare infrastructure, will positively benefit the worldwide meningococcal vaccines market. Furthermore, an increase in meningococcal vaccine research and development efforts is likely to drive the worldwide meningococcal vaccines market growth.
Market Restraints
Stringent government norms and regulations for approval, on the other hand, are projected to stymie the worldwide meningococcal vaccines market growth. Furthermore, the recall of numerous products owing to contamination would have an impact on the worldwide meningococcal vaccines market growth.
Market Segmentation
Global Meningococcal Vaccines Market is segmented into vaccine serotype such as MenAC, MenA, MenC, MenB & Manic, and MenACWY, by vaccine type such as Subcapsular, Polysaccharide, and Conjugate. Further, Global Meningococcal Vaccines Market is segmented into end user such as Adult, Pediatric, and Travelers.
Also, Global Meningococcal Vaccines Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the Meningococcal Vaccines market. Favourable government recommendations and support, as well as significant R&D investments, are some of the drivers driving the North America market. Furthermore, a well-developed healthcare infrastructure and increased awareness campaigns in the region are expected to drive market growth.
Market Key Players
Various key players are discussed in this report such as Serum Institute of India Pvt. Ltd, Emergent BioSolutions, Inc, Sanofi, Merck & Co., Inc, GlaxoSmithKline, plc, and Pfizer Inc. etc.
Market Taxonomy
By Vaccine Serotype
- MenAC
- MenA
- MenC
- MenB & Manic
- MenACWY
- Subcapsular
- Polysaccharide
- Conjugate
- Adult
- Pediatric
- Travelers
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- 1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Meningococcal Vaccines Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Meningococcal Vaccines Market, By Vaccine Serotype
- 5.1 Y-o-Y Growth Comparison, By Vaccine Serotype
- 5.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 5.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Serotype
- 5.3.1 MenAc
- 5.3.2MenA
- 5.3.3 MenC
- 5.3.4 MenB & Manic
- 5.3.5MenACWY
- 6 Global Meningococcal Vaccines Market, By Vaccine Type
- 6.1 Y-o-Y Growth Comparison, By Vaccine Type
- 6.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Type
- 6.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 6.3.1 Subcapsular
- 6.3.2 Polysaccharide
- 6.3.3 Conjugate
- 7 Global Meningococcal Vaccines Market, By End User
- 7.1 Y-o-Y Growth Comparison, By End User
- 7.2 Global Meningococcal Vaccines Market Share Analysis, By End User
- 7.3 Global Meningococcal Vaccines Market Size and Forecast, By End User
- 7.3.1 Adult
- 7.3.2 Paediatric
- 7.3.3 Travelers
- 8 Global Meningococcal Vaccines Market, By Region
- 8.1 Global Meningococcal Vaccines Market Share Analysis, By Region
- 8.2 Global Meningococcal Vaccines Market Share Analysis, By Region
- 8.3 Global Meningococcal Vaccines Market Size and Forecast, By Region
- 9 North America Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
- 9.1 Introduction
- 9.2 North America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 9.3 North America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 9.4 North America Meningococcal Vaccines Market Size and Forecast, By End User
- 9.5 North America Meningococcal Vaccines Market Size and Forecast, By Country
- 9.5.1 U.S.
- 9.5.2 Canada
- 9.5.3 Mexico
- 10 Europe Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
- 10.1 Introduction
- 10.2 Europe Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 10.3 Europe Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 10.4 Europe Meningococcal Vaccines Market Size and Forecast, By End User
- 10.5 Europe Meningococcal Vaccines Market Size and Forecast, By Country
- 10.5.1 Germany
- 10.5.2 France
- 10.5.3 UK
- 10.54. Rest of Europe
- 11 Asia Pacific Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
- 11.1 Introduction
- 11.2 Asia Pacific Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 11.3 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 11.4 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By End User
- 11.5 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Country
- 11.5.1 China
- 11.5.2 Japan
- 11.5.3 India
- 11.5.4. Rest of Asia Pacific
- 12 Latin America Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
- 12.1 Introduction
- 12.2 Latin America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 12.3 Latin America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 12.4 Latin America Meningococcal Vaccines Market Size and Forecast, By End User
- 12.5 Latin America Meningococcal Vaccines Market Size and Forecast, Country
- 13Middle East Meningococcal Vaccines Market Analysis and Forecast (2022 – 2027)
- 13.1 Introduction
- 13.2 Middle East Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
- 13.3 Middle East Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
- 13.4 Middle East Meningococcal Vaccines Market Size and Forecast, By End User
- 13.5 Middle East Meningococcal Vaccines Market Size and Forecast, By Country
- 14 Competitive Analysis
- 14.1 Competition Dashboard
- 14.2 Market share Analysis of Top Vendors
- 14.3 Key Development Strategies
- 15 Company Profiles
- 15.1 Serum Institute of India Pvt. Ltd
- 15.1.1 Overview
- 15.1.2 Offerings
- 15.1.3 Key Financials
- 15.1.4 Business Segment & Geographic Overview
- 15.1.5 Key Market Developments
- 15.1.6 Key Strategies
- 15.2 Emergent BioSolutions, Inc
- 15.2.1 Overview
- 15.2.2 Offerings
- 15.2.3 Key Financials
- 15.2.4 Business Segment & Geographic Overview
- 15.2.5 Key Market Developments
- 15.2.6 Key Strategies
- 15.3 Sanofi
- 15.3.1 Overview
- 15.3.2 Offerings
- 15.3.3 Key Financials
- 15.3.4 Business Segment & Geographic Overview
- 15.3.5 Key Market Developments
- 15.3.6 Key Strategies
- 15.4 Merck & Co., Inc
- 15.4.1 Overview
- 15.4.2 Offerings
- 15.4.3 Key Financials
- 15.4.4 Business Segment & Geographic Overview
- 15.4.5 Key Market Developments
- 15.4.6 Key Strategies
- 15.5 GlaxoSmithKline, plc
- 15.5.1 Overview
- 15.5.2 Offerings
- 15.5.3 Key Financials
- 15.5.4 Business Segment & Geographic Overview
- 15.5.5 Key Market Developments
- 15.5.6 Key Strategies
- 15.6 Pfizer Inc
- 15.6.1 Overview
- 15.6.2 Offerings
- 15.6.3 Key Financials
- 15.6.4 Business Segment & Geographic Overview
- 15.6.5 Key Market Developments
- 15.6.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook